Allarity Therapeutics Inc
ALLR
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.43M
Close$
$1.16
19.1% downside
Current Fair Value
19.1% downsideOvervalued by 19.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.43 Million |
|---|---|
| Enterprise Value | $5.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.51 |
| Outstanding Shares | 15,910,724 |
Return
| Return on Equity | -31.19% |
|---|---|
| Return on Assets | -3.43% |
| Return on Invested Capital | -304.61% |
Valuation & Multiples
| P/E Ratio | -1.81 |
|---|---|
| PEG | -3.87 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.04 |
| Enterprise Value to EBIT | -0.51 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$25,000
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data